Helicobacter Pylori Eradication Composition With pH-Stabilizing P-CAB
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The increasing resistance of Helicobacter pylori to antibiotics, particularly clarithromycin, has led to a decrease in eradication rates, and maintaining an optimal intragastric pH is crucial for effective antibiotic action, but existing treatments face challenges in achieving and sustaining this pH for sufficient eradication.
Innovation Solution
A pharmaceutical composition comprising a benzimidazole derivative, amoxicillin, and clarithromycin, which acts as a potassium-competitive acid blocker to maintain an intragastric pH of 5 or more, enhancing the stability and efficacy of antibiotics by increasing their bioavailability and reducing minimum inhibitory concentrations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If standard triple therapy with amoxicillin and clarithromycin is used, then eradication treatment is provided, but eradication rate decreases due to increasing antibiotic resistance
Solution Approach 1:
The patent changes the pH parameter of the gastric environment by introducing a potassium-competitive acid blocker (P-CAB) that maintains intragastric pH at 5 or more. This parameter change creates an optimal environment for antibiotic efficacy while countering the harmful effect of antibiotic resistance, thereby improving the eradication rate.
2Reliability
If intragastric pH is maintained at 5 or more, then antibiotic stability and efficacy are enhanced, but this requires additional pH control intervention
Solution Approach 1:
The patent introduces a potassium-competitive acid blocker (P-CAB) as an intermediary substance that mediates between the stomach's acid secretion and the antibiotics. This P-CAB maintains intragastric pH at 5 or more, creating an optimal environment for antibiotic stability and efficacy without requiring complex pH control mechanisms.
3Reliability
If antibiotics are administered for extended period, then eradication is achieved, but resistant bacteria growth increases
Solution Approach 1:
The patent applies preliminary action by maintaining intragastric pH at 5 or more throughout the antibiotic treatment period. This preliminary pH control creates an environment that prevents resistant bacteria from developing during the extended antibiotic administration, thereby achieving complete eradication without promoting harmful resistant bacteria growth.
4Quantity of substance
If pH is maintained close to pKa value of antibiotics, then minimum inhibitory concentration is reduced, but this requires precise pH control
Solution Approach 1:
The patent changes the pH parameter to match the pKa value of the antibiotics (maintaining pH at 5 or more). This parameter change reduces the minimum inhibitory concentration required for antibiotic efficacy. The P-CAB achieves this pH control in a manner that does not require excessive precision, balancing effectiveness with practical controllability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively eradicates Helicobacter pylori, including resistant strains, by maintaining a high intragastric pH for an extended period, thereby maximizing the eradication effect of amoxicillin and clarithromycin, and improving treatment compliance.
Implementation Method 1
a certain benzimidazole derivative compound shows an excellent effect on a pH growth in the stomach and exhibits a remarkable effect on eradicating Helicobacter pylori
Implementation Method 2
maintaining pH close to a pKa value unique to antibiotics, thereby increasing stability of the antibiotics and reducing a minimum inhibitory concentration of the antibiotics on Helicobacter pylori
Data Source
AI summary
The present invention relates to a composition for eradicating Helicobacter pylori and a use thereof. The composition of the present invention maintains an intragastric pH at a certain level or more for a certain period of time or longer, thereby maximizing an action of amoxicillin and clarithromycin to show an excellent effect on eradicating Helicobacter pylori.